72.45EUR-2.23%Mkt Cap: 8.45B EURP/E: 21.45Last update: 2026-05-14
bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It ope…
Industry Peers
Diagnostics & Researchloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)21.45
P/E (Forward)14.37
PEG1.33
P/B2.06
P/S2.08
EV/EBITDA7.39
EV/Revenue2.05
EPS (TTM)3.34
EPS (Forward)4.98
Cash Flow & Leverage
FCF Yield7.29%
FCF Margin15.13%
Operating CF788.40M EUR
CapEx (TTM)335.30M EUR
Net Debt/EBITDA-0.10
Net Debt-108.40M EUR
Technical
SMA 5085.96 (-15.7%)
SMA 200103.58 (-30.1%)
Beta0.54
S&P 52W Chg24.23%
Avg Vol (30d)218.64K
Avg Vol (10d)289.96K
Technical Indicators
RSI (14)35.0
MACD-4.4500
MACD Signal-5.0295
MACD Hist.+0.5795
BB Upper93.22 EUR
BB Middle76.19 EUR
BB Lower59.16 EUR
BB Width44.70%
ATR (14)2.397 EUR
Vol Ratio (20d)0.87x
52W Range
68.057% of range128.30
52W High128.30 EUR
52W Low68.05 EUR
Profitability
Gross Margin56.73%
EBITDA Margin27.76%
Profit Margin9.77%
Oper. Margin16.81%
ROE9.69%
ROA7.13%
Revenue Growth-2.50%
Earnings Growth9.40%
Balance Sheet
Debt/Equity0.11
Current Ratio2.39
Quick Ratio1.42
Book Value/Sh34.77 EUR
Cash/Share4.831 EUR
Dividends
Fwd Div Rate0.9800 EUR
Trail. Div Rate0.9800 EUR
Div. Yield1.37%
5Y Avg Yield0.80%
Payout Ratio26.95%
Ex-Div DateJun 9, 2026
Pay Date—
Splits
Last Split3:1
Split DateSep 20, 2017
Ownership
Shares Out.117.95M
Float44.62M
Insiders66.46%
Institutions18.47%
Analyst Consensus
Rating2.5 (Buy)
Target (Mean)99.08 EUR
Target Range71.60 EUR – 138.00 EUR
# Analysts13
Company
Market Cap8.45B EUR
Enterprise Value8.35B EUR
Revenue (TTM)4.07B EUR
Gross Profit2.31B EUR
Net Income (TTM)397.50M EUR
Revenue/Share34.49 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees14.6K
Last Price72.45 EUR
CountryFR
SectorHealthcare
IndustryDiagnostics & Research
ISINFR0013280286